GlassScriptPhysician profile
Scott Costin
NPI 1942223698
$9,125.91
in general payments reported to CMS, 2019-2025
41 companies · $1,408 in 2025
The $1,408 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,269 · 2020: $765 · 2021: $1,317 · 2022: $1,370 · 2023: $1,493 · 2024: $1,504 · 2025: $1,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,404.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,291.37 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $878.11 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $811.00 | 2019-2025 | Farxiga, Airsupra, Andexxa |
| Lilly USA, LLC | $692.03 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $686.70 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $516.53 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $443.45 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $383.50 | 2022-2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $361.90 | 2019-2024 | Livalo |
| Amarin Pharma, INC. | $338.11 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $300.58 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $234.10 | 2019-2025 | Trintellix |
| Astellas Pharma US INC | $181.46 | 2019-2024 | Veozah |
| Amgen INC. | $176.34 | 2020-2025 | Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $165.52 | 2021-2024 | Xarelto |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Costin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.